The Huberman Lab
The Huberman Lab

Essentials: ADHD & How Anyone Can Improve Their Focus

In this Huberman Lab Essentials episode, I explore the biology and psychology of attention-deficit/hyperactivity disorder (ADHD), and discuss both prescription and non-prescription treatment options. I discuss the neural circuits involved in attention and concentration, emphasizing dopamine's r

Featured Speakers

Scicomm Media Host

Topics Discussed

Episode Summary

Executive Summary: The episode explains ADHD as a disorder of attention, impulse control, time perception, and working memory linked to low dopamine and disrupted coordination between default mode and task networks. It reviews prescription stimulants, emerging supplements, behavioral training for focus, and warns that smartphones may erode attention even in non-ADHD listeners.

Main Topics: ADHD phenotype and diagnosis (Priority: 5/5): Defines ADHD as difficulty sustaining attention, impulsivity, emotional reactivity, time misperception, and working-memory problems, while noting hyperfocus on highly rewarding tasks and cautioning against self-diagnosis. Dopamine and brain network coordination (Priority: 5/5): Frames attention as a dopamine-dependent process that narrows sensory focus and helps keep default mode and task networks anti-correlated; low dopamine is presented as a core mechanism in ADHD. Prescription stimulant treatments (Priority: 5/5): Reviews methylphenidate/Ritalin, Adderall, modafinil, and armodafinil as dopamine- and norepinephrine-boosting drugs that can improve focus but carry addiction, cardiovascular, and sexual side effects. Behavioral training for attention (Priority: 4/5): Describes attentional blinks, open monitoring, panoramic vision, and blink control as trainable mechanisms that can improve focus, with some effects reported after brief practice. Supplements and non-prescription approaches (Priority: 4/5): Discusses omega-3s (especially DHA), phosphatidylserine, alpha-GPC, and L-tyrosine as compounds that may support attention, with caution about dosing and psychiatric risk. Smartphones and attentional erosion (Priority: 4/5): Argues that rapid context switching on phones may train fragmented attention and recommends limiting daily use to preserve focus capacity.

Key Arguments: ADHD is not just poor attention; it also involves impulsivity, emotionality, time blindness, and working-memory deficits. People with ADHD can hyperfocus when tasks are intrinsically rewarding, suggesting the capacity to attend is present but poorly recruited. Dopamine is the key neurochemical for narrowing attention and coordinating brain networks that support goal-directed behavior. Low dopamine may cause irrelevant neural firing and poor synchronization between default mode and task networks. Stimulant medications work because they raise dopamine and norepinephrine, improving focus in many patients. Some stimulant use may reflect self-medication rather than mere impulsivity, because dopamine-raising substances can temporarily normalize attention. Early treatment may be especially useful because childhood neuroplasticity is high and can help train executive circuits. Attentional blinks show that over-focusing can cause missed information; training open monitoring may reduce these blinks. Blink rate and time perception are linked to dopamine, helping explain why ADHD is associated with lateness and underestimating time. Omega-3s, phosphatidylserine, alpha-GPC, and tyrosine may support attention, but effects and safety depend on dose and individual context. Heavy smartphone use may degrade sustained attention by repeatedly forcing rapid context switching. Behavioral training should ideally accompany medication so the brain learns to use focus circuits without relying solely on drugs.

Data Points: Children with ADHD: about 1 in 10, probably more - Current estimate cited at the start of the episode Treatment response: about half resolve with proper treatment - Speaker notes that roughly half of childhood ADHD cases resolve Body temperature change for sleep: 1 to 3 degrees - Used in sponsor segment to explain sleep temperature regulation Pod 5 discount: up to $350 off - Eight Sleep sponsor offer Omega-3 DHA threshold: above 300 mg/day - Speaker says attentional effects appear around this DHA level Phosphatidylserine dose: 200 mg/day for 2 months - Reported to reduce ADHD symptoms in children Alpha-GPC dose: up to 1,200 mg/day - High dose cited for age-related cognitive decline Typical alpha-GPC study-use dose: 300-600 mg/day - Common range mentioned for learning/focus use L-tyrosine dose range: 100-1,200 mg - Wide dosing range noted with caution Childhood neuroplasticity window: approximately age 3 to 12 or 13 - Speaker emphasizes high plasticity during this period Neuroplasticity decline: tapers off after about age 25 - Used to justify early intervention Attentional blink training session: 17 minutes - Open-gaze practice reportedly reduced attentional blinks after one session Fixation-focused training duration: a few minutes each day - Elementary school attention training study Smartphone limit for adolescents: 60 minutes/day or less - Speaker recommendation to preserve attention Smartphone limit for adults: 2 hours/day or less - Speaker recommendation to preserve attention

Pivotal Quotes: "attention, focus, and concentration are essentially the same thing" — Andrew Huberman: Defines the episode’s working framework for ADHD and attention "What dopamine is doing in this context is dopamine is acting like a conductor" — Andrew Huberman: Explains dopamine’s role in coordinating default mode and task networks "we are inducing a sort of ADHD" — Andrew Huberman: Warns that smartphone use may fragment attention and mimic ADHD-like patterns

Implications: Listeners should view ADHD as a dopamine- and network-based regulation problem, not just distractibility. Treatment may combine medication, behavioral training, sleep, and reduced phone use; the supplement and stimulant options discussed require medical caution.

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab